Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance study of 14C-ONO-2808 in healthy Japanese adult males
jRCT2071240057Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ONO-2808, sponsored by Ono Pharmaceutical. Primary endpoints: Urinary excretion rate of radioactivity, Fecal excretion rate of radioactivity and 1 more. Started Nov 2024; status: completed.
02
Drugs
ONO-2808
Beyond the preview
Go deeper on jRCT2071240057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071240057.